Annual report pursuant to Section 13 and 15(d)

Note 11 - Stockholders' Deficit (Tables)

v3.6.0.2
Note 11 - Stockholders' Deficit (Tables)
12 Months Ended
Dec. 31, 2016
Equity [Abstract]  
Schedule of Stockholders Equity

For the year ended December 31, 2016, the Company had the following transactions related to its common stock including restricted stock awards (in thousands, except share and per share data):

Transaction Type   Quantity (Shares)    

Valuation

($)

   

Range of

Value per Share

 
Shares issued to employees, executives and directors   572,154     $ 1,367     $ 1.89-2.95  
Shares issued related to sale of subsidiary   200,000       640     $ 3.20  
Cancellation and forfeiture of restricted stock   (449,085 )     (456 )   $ 2.72-13.00  
Total   323,069     $ 1,551     $ 1.89-13.00  

 

 

For the year ended December 31, 2015, the Company issued common stock including restricted stock awards, as follows (in thousands, except share and per share data):

Transaction Type  

Quantity

(Shares)

 

Valuation

($)

  Range of Value per Share
Stock issued to employees, executives and directors, net of cancellations     214,394     $ 766     $ 3.82-8.60  
Stock issued for product line expansion     150,000       1,198     $ 7.99  
Stock issued for MusclePharm apparel rights acquisition     170,000       1,394     $ 8.20  
Stock issued for financing agreement     50,000       325     $ 6.49  
Stock issued for consulting/endorsement agreement     55,189       320     $ 5.30-5.85  
Stock issued for individual guaranty of debt     28,571       80     $ 2.80  
Total     668,154     $ 4,083     $ 2.80-8.60